Trial intelligence / Profile preview

Phase 3 trial of Fibrocaps for intraoperative surgical hemostasis

NL-OMON39278Phase 3Active, not recruiting

Sponsor
The Medicines Company
Start
Aug 2012
Modality
Recombinant Proteins and Enzymes, Device-based Delivery → Drug Delivery Systems
Countries
1
01

Overview

Phase 3 trial of tachosil, sponsored by The Medicines Company. Started Aug 2012; status: active, not recruiting.

02

Drugs

tachosil

Beyond the preview

Go deeper on NL-OMON39278.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON39278.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call